Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.94 USD | -1.38% | -1.71% | -14.30% |
03:25pm | Everlasting momentum | |
12:49pm | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.30% | 9.03TCr | |
+33.15% | 71TCr | |
+30.77% | 60TCr | |
-2.02% | 37TCr | |
+20.00% | 33TCr | |
+5.23% | 29TCr | |
+14.77% | 24TCr | |
+9.13% | 21TCr | |
-3.97% | 20TCr | |
+9.35% | 17TCr |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Goldman Sachs Cuts Bristol-Myers Squibb's Price Target to $56 From $60